NanoString Explores Sale Options in the Face of Bankruptcy and Patent Conflict with 10x Genomics
NanoString Technologies, a leading provider of life science tools and molecular diagnostic products, has officially filed for bankruptcy, as the company faces increasing pressure from its ongoing patent battle with its competitor, 10x Genomics. In an effort to sustain its operations and protect its assets, NanoString is also exploring the possibility of a potential sale.
